An in-depth look to PCI BIOTECH HOLDING ASA NOK 0.03 operating, investing, and financing activities

0JGL free cash flow for H2 24 is -3.29 M NOK. For 2024, 0JGL free cash flow was -13.76 M NOK and operating cash flow was -13.76 M NOK.